Melanotan II is a synthetic, non-selective melanocortin receptor agonist originally developed in the 1990s at the University of Arizona as a candidate for sunless-tanning and libido research.
🔬 Studied for: Pigmentation Research
💊 Also studied for: Appetite & Libido Research
🧪 Not FDA-approved — sold strictly for laboratory research
📈 No standardized human dosage established in published literature
Melanotan II is a synthetic, non-selective melanocortin receptor agonist originally developed in the 1990s at the University of Arizona as a candidate for sunless-tanning and libido research. It has never received FDA approval, though it has been studied and discussed extensively outside regulated clinical channels.
Unlike PT-141 (Bremelanotide), which was refined for MC4R selectivity, Melanotan II activates multiple melanocortin receptor subtypes (MC1R, MC3R, MC4R, and MC5R) non-selectively, which researchers have linked both to its pigmentation effects (via MC1R) and its broader, less predictable side-effect profile.
These are effects Melanotan II has been studied for in available preclinical and early research — not claims about guaranteed outcomes.
Melanotan II's activation of MC1R on melanocytes is the basis for its most-studied effect — stimulating melanin production — and it has been examined in research on skin pigmentation and photoprotection.
Its activity at MC3R and MC4R has made Melanotan II a subject of research into appetite regulation and sexual arousal, though its lack of receptor selectivity is precisely why later compounds like Bremelanotide were developed to isolate the MC4R effect specifically.
No FDA-approved or clinically established human dosage exists for Melanotan II; unregulated products carry additional risk given documented cases of contamination and mislabeling in illicit supply chains reported in toxicology literature.
Compound X does not provide dosing recommendations. Melanotan II is sold for laboratory research use only and is not intended for human consumption.
Melanotan II has never been FDA-approved, and case reports in the medical literature have documented adverse effects including nausea, flushing, spontaneous erections, darkening of existing moles, and rare reports of new melanocytic lesions — the latter being a specific concern given its mechanism of action on pigment-producing cells.
No. Melanotan II is not FDA-approved for any indication and is sold strictly as a research chemical, not a medication or dietary supplement.
Pigmentation Research — Melanotan II's activation of MC1R on melanocytes is the basis for its most-studied effect — stimulating melanin production — and it has been examined in research on skin pigmentation and photoprotection.
In the US, UK, Canada and Australia, Melanotan II is generally sold labeled "for research use only, not for human consumption." It is not approved as a dietary supplement or medication in any of these countries.
Melanotan II safety case reports and pharmacology are indexed on PubMed under "Melanotan II melanocortin adverse effects."
Compare current prices, purity testing claims and coupon codes across every vendor Compound X tracks.
New guides, vendor comparisons and compound breakdowns every week.